2010
DOI: 10.3109/00016480903143986
|View full text |Cite
|
Sign up to set email alerts
|

Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease

Abstract: Endolymphatic hydrops was observed in the ears of patients with Ménière's disease. However, Gd concentration in the perilymph was lower compared with that obtained after intratympanic Gd injection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
56
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 98 publications
(59 citation statements)
references
References 10 publications
2
56
0
1
Order By: Relevance
“…4 Grading has also been applied to images obtained after double-and single-dose IV-GBCM. 3,10 Especially, acquisition of hT 2 W-3D-FLAIR images after IV-SD-GBCM is expected to spread widely in the clinicalˆeld because of the low No cochlear endolymphatic hydrops is seen. There is very smallˆlling defect at the location of the cochlear endolymph (short arrows).…”
Section: Discussionmentioning
confidence: 99%
“…4 Grading has also been applied to images obtained after double-and single-dose IV-GBCM. 3,10 Especially, acquisition of hT 2 W-3D-FLAIR images after IV-SD-GBCM is expected to spread widely in the clinicalˆeld because of the low No cochlear endolymphatic hydrops is seen. There is very smallˆlling defect at the location of the cochlear endolymph (short arrows).…”
Section: Discussionmentioning
confidence: 99%
“…28 The reports describing intratympanic gadolinium injection in human subjects have been published from several institutions, including ours, [11][12][13][14][15][23][24][25][29][30][31] and no marked side effects in the inner ear relating to intratympanic gadolinium injection have been reported on clinical application at present, to the best of our knowledge. In addition, intravenously administered gadolinium has been reported to infiltrate inner ear perilymph, 16,17,22,23 and no marked side effects in the inner ear relating to IV gadolinium injection have been reported in the clinical application at present. Therefore, gadolinium agent use in the clinical setting appears safe for inner ear imaging, but future study requires continued vigilance regarding the small possibility of side effects.…”
Section: Figmentioning
confidence: 99%
“…11 Intravenously administered gadolinium agent also distributes into the perilymph space of the scala tympani through the blood-perilymph barrier, and elevation of the cochlear basal turn signal intensity is most easily observed 4 hours after IV gadolinium injection on 3D-FLAIR in human subjects. 16,22,23 The region of interest of the medulla oblongata was set on the center of the medulla oblongata at the identical section of the basal turn of the cochlea. The region of interest of the medulla oblongata did not include the signal intensity of CSF or vessels.…”
Section: Mr Imaging Evaluation and Statistical Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…A combination of double-dose IV-GBCM and 3D-FLAIR imaging enabled the visualization of EH. [98][99][100] Usually, 4 h after IV-GBCM, MR imaging can be conducted.…”
Section: Endolymphatic Hydropsmentioning
confidence: 99%